Fig. 9From: Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathwaySchematic diagram of the proposed mechanisms for Dihydromyricetin ameliorating hepatic steatosis and IR in HFD-induced rats via the AMPK/PGC-1α and PPARα-mediated autophagy pathwaysBack to article page